Analysis Ribomic Inc. (4591)
5/30/2024
Analysis of Ribomic Inc. (4591)
Ribomic Inc. (symbol: 4591) has been showing some fluctuations in its stock price recently. The RSI indicator has been hovering around the 50 level, indicating a neutral sentiment in the market. The MACD indicator has been negative, but the MACD histogram has shown some positive values, suggesting a potential reversal in the trend.The moving averages (SMA, EMA, WMA) have been relatively close to each other, indicating a lack of strong trend direction. The stock price has been trading within a range, with some volatility in the past few days.
Overall, Ribomic Inc. seems to be consolidating and preparing for a potential breakout in either direction. Traders and investors may want to closely monitor the stock for any significant developments that could indicate a change in the current trend.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has experienced significant growth in the past but is expected to see a more moderate growth rate in the coming years. The next year is expected to show a higher growth rate compared to the current year, and the company is projected to maintain double-digit growth over the next 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has an average 10-day volume of 46.86 million and an average 90-day volume of 57.50 million. The stock price summary includes a beta of 1.264, a 50-day moving average of $176.26, and a 200-day moving average of $181.04.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The company's market capitalization is $2.92 trillion.
Lastly, dividends and splits information indicates a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend dates, split dates, and dividend yields are also provided.
Income statement 💸
Here are the revenue figures for the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from 2022 to 2023.
- Sales have generally been increasing over the past four years, with a significant jump from 2020 to 2021.
- The company's revenue has shown growth over the years, indicating a positive trend in its business operations.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $255.4 billion in 2018 to $290.4 billion in 2023.
5. Shareholders' equity has shown fluctuations but has increased overall, from $107.1 billion in 2018 to $62.1 billion in 2023.
Cash Flow 💶
This is the cash flow statement. Here are some key takeaways from the data:1. The company's free cash flow has been fluctuating over the years, with a significant increase in 2022 compared to 2021 and a slight decrease in 2023.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been paying a significant amount in income taxes and interest, which impacts its overall cash position.
4. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
5. Investing activities include acquisitions, capital expenditures, and the sale/purchase of investments, which have varied over the years.
6. The end cash position has also fluctuated, with the company ending with a higher cash balance in 2021 and 2023 compared to 2020 and 2022.
These insights provide a snapshot of the company's cash flow dynamics and financial performance over the past few years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next year. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
MACD of 4591
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
